Skip to main content

Click Here to Learn More About trial interactive’s mobile-first CTMS

Investigator Database

Identify Investigative Sites

Fast and Simple Site Identification

Trial Interactive’s powerful site/investigator database helps expedite the path to site activation by making it easy to identify and prequalify relevant sites around the world. Over 50% of sites fail to successfully enroll patients. Easily search for, qualify, and see sites through to activation to avoid enrollment challenges and loss of investments.

Investigator Database Highlights

  • Search an Exhaustive Collection of Public Data
  • Leverage Your Historical Site/Investigator Data
  • Search & Filter Sites and Investigators
  • Save Site/Investigator Collections
  • Identify Sites Through Study Start-Up
  • Speed SFQs & Enhance Site/Investigator Data
  • Multilingual Translation Support
  • 24/7 Help Desk (Email/Phone Support)
Learn More

Start Simplifying Site Identification Now!

  • Find Global Sites and Investigators with Ease

  • Quickly Identify Relevant Sites and Investigators

  • Reuse Site and Investigator Collections

  • Save 25% on Patient Enrollment Costs

  • Avoid Delays and Shorten Activation Time by 8 Months

  • Reduce Risk of Site Failure by Identifying the Best-Fit Sites

Identify investigators and sites from accredited public sources like clinicaltrials.gov, NIHR, and PubMed among others—providing detailed records for over 300,000 investigators and 100,000 sites.

  • Import historical investigator and site data to build a proprietary database tailored to your research requirements.
  • Search Investigator Database’s extensive database, and filter results based on study-specific parameters—including, but not limited to, geographical location, therapeutic area, training, past experience in clinical trials, and contact information—to find the best-fit sites.
  • Create collections of investigators and sites to aid in future site identification efforts and to expedite feasibility.
  • Send data to TI eFeasibility to start sending site feasibility questionnaires and send response data back to Investigator Database to further enhance site and investigator data for future studies.
  • Ensure efficiency in your patient enrollment budget by identifying best-fit sites to lower risks of failed sites.